Highlights
The global Lung Transplant market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Lung Transplant is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Lung Transplant is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Lung Transplant in Medical is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Lung Transplant include Mayo Clinic, UCSF, Penn medicine, Baylor College of Medicine, Cleveland Clinic, Stanford Health Care, University Health Network, Brigham and Women's Hospital and UC San Diego Health, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Lung Transplant, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung Transplant.
The Lung Transplant market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Lung Transplant market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lung Transplant companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Mayo Clinic
UCSF
Penn medicine
Baylor College of Medicine
Cleveland Clinic
Stanford Health Care
University Health Network
Brigham and Women's Hospital
UC San Diego Health
Columbia Surgery
UMMC
Temple Lung Centre
UW Health
Duke Health
NYU Langone Transplant Institute
University of Michigan Transplant Center
Segment by Type
Single Lung Transplant
Double Lung Transplant
Heart-lung Transplant
Segment by Application
Medical
Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lung Transplant companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Lung Transplant 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Single Lung Transplant
1.2.3 Double Lung Transplant
1.2.4 Heart-lung Transplant
1.3 麻豆原创 by Application
1.3.1 Global Lung Transplant 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Medical
1.3.3 Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lung Transplant 麻豆原创 Perspective (2018-2029)
2.2 Lung Transplant Growth Trends by Region
2.2.1 Global Lung Transplant 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Lung Transplant Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Lung Transplant Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Lung Transplant 麻豆原创 Dynamics
2.3.1 Lung Transplant Industry Trends
2.3.2 Lung Transplant 麻豆原创 Drivers
2.3.3 Lung Transplant 麻豆原创 Challenges
2.3.4 Lung Transplant 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lung Transplant Players by Revenue
3.1.1 Global Top Lung Transplant Players by Revenue (2018-2023)
3.1.2 Global Lung Transplant Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Lung Transplant 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Lung Transplant Revenue
3.4 Global Lung Transplant 麻豆原创 Concentration Ratio
3.4.1 Global Lung Transplant 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Transplant Revenue in 2022
3.5 Lung Transplant Key Players Head office and Area Served
3.6 Key Players Lung Transplant Product Solution and Service
3.7 Date of Enter into Lung Transplant 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Lung Transplant Breakdown Data by Type
4.1 Global Lung Transplant Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Lung Transplant Forecasted 麻豆原创 Size by Type (2024-2029)
5 Lung Transplant Breakdown Data by Application
5.1 Global Lung Transplant Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Lung Transplant Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Lung Transplant 麻豆原创 Size (2018-2029)
6.2 North America Lung Transplant 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Lung Transplant 麻豆原创 Size by Country (2018-2023)
6.4 North America Lung Transplant 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lung Transplant 麻豆原创 Size (2018-2029)
7.2 Europe Lung Transplant 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Lung Transplant 麻豆原创 Size by Country (2018-2023)
7.4 Europe Lung Transplant 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lung Transplant 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Lung Transplant 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Lung Transplant 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Lung Transplant 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lung Transplant 麻豆原创 Size (2018-2029)
9.2 Latin America Lung Transplant 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Lung Transplant 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Lung Transplant 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lung Transplant 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Lung Transplant 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Lung Transplant 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Lung Transplant 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Mayo Clinic
11.1.1 Mayo Clinic Company Detail
11.1.2 Mayo Clinic Business Overview
11.1.3 Mayo Clinic Lung Transplant Introduction
11.1.4 Mayo Clinic Revenue in Lung Transplant Business (2018-2023)
11.1.5 Mayo Clinic Recent Development
11.2 UCSF
11.2.1 UCSF Company Detail
11.2.2 UCSF Business Overview
11.2.3 UCSF Lung Transplant Introduction
11.2.4 UCSF Revenue in Lung Transplant Business (2018-2023)
11.2.5 UCSF Recent Development
11.3 Penn medicine
11.3.1 Penn medicine Company Detail
11.3.2 Penn medicine Business Overview
11.3.3 Penn medicine Lung Transplant Introduction
11.3.4 Penn medicine Revenue in Lung Transplant Business (2018-2023)
11.3.5 Penn medicine Recent Development
11.4 Baylor College of Medicine
11.4.1 Baylor College of Medicine Company Detail
11.4.2 Baylor College of Medicine Business Overview
11.4.3 Baylor College of Medicine Lung Transplant Introduction
11.4.4 Baylor College of Medicine Revenue in Lung Transplant Business (2018-2023)
11.4.5 Baylor College of Medicine Recent Development
11.5 Cleveland Clinic
11.5.1 Cleveland Clinic Company Detail
11.5.2 Cleveland Clinic Business Overview
11.5.3 Cleveland Clinic Lung Transplant Introduction
11.5.4 Cleveland Clinic Revenue in Lung Transplant Business (2018-2023)
11.5.5 Cleveland Clinic Recent Development
11.6 Stanford Health Care
11.6.1 Stanford Health Care Company Detail
11.6.2 Stanford Health Care Business Overview
11.6.3 Stanford Health Care Lung Transplant Introduction
11.6.4 Stanford Health Care Revenue in Lung Transplant Business (2018-2023)
11.6.5 Stanford Health Care Recent Development
11.7 University Health Network
11.7.1 University Health Network Company Detail
11.7.2 University Health Network Business Overview
11.7.3 University Health Network Lung Transplant Introduction
11.7.4 University Health Network Revenue in Lung Transplant Business (2018-2023)
11.7.5 University Health Network Recent Development
11.8 Brigham and Women's Hospital
11.8.1 Brigham and Women's Hospital Company Detail
11.8.2 Brigham and Women's Hospital Business Overview
11.8.3 Brigham and Women's Hospital Lung Transplant Introduction
11.8.4 Brigham and Women's Hospital Revenue in Lung Transplant Business (2018-2023)
11.8.5 Brigham and Women's Hospital Recent Development
11.9 UC San Diego Health
11.9.1 UC San Diego Health Company Detail
11.9.2 UC San Diego Health Business Overview
11.9.3 UC San Diego Health Lung Transplant Introduction
11.9.4 UC San Diego Health Revenue in Lung Transplant Business (2018-2023)
11.9.5 UC San Diego Health Recent Development
11.10 Columbia Surgery
11.10.1 Columbia Surgery Company Detail
11.10.2 Columbia Surgery Business Overview
11.10.3 Columbia Surgery Lung Transplant Introduction
11.10.4 Columbia Surgery Revenue in Lung Transplant Business (2018-2023)
11.10.5 Columbia Surgery Recent Development
11.11 UMMC
11.11.1 UMMC Company Detail
11.11.2 UMMC Business Overview
11.11.3 UMMC Lung Transplant Introduction
11.11.4 UMMC Revenue in Lung Transplant Business (2018-2023)
11.11.5 UMMC Recent Development
11.12 Temple Lung Centre
11.12.1 Temple Lung Centre Company Detail
11.12.2 Temple Lung Centre Business Overview
11.12.3 Temple Lung Centre Lung Transplant Introduction
11.12.4 Temple Lung Centre Revenue in Lung Transplant Business (2018-2023)
11.12.5 Temple Lung Centre Recent Development
11.13 UW Health
11.13.1 UW Health Company Detail
11.13.2 UW Health Business Overview
11.13.3 UW Health Lung Transplant Introduction
11.13.4 UW Health Revenue in Lung Transplant Business (2018-2023)
11.13.5 UW Health Recent Development
11.14 Duke Health
11.14.1 Duke Health Company Detail
11.14.2 Duke Health Business Overview
11.14.3 Duke Health Lung Transplant Introduction
11.14.4 Duke Health Revenue in Lung Transplant Business (2018-2023)
11.14.5 Duke Health Recent Development
11.15 NYU Langone Transplant Institute
11.15.1 NYU Langone Transplant Institute Company Detail
11.15.2 NYU Langone Transplant Institute Business Overview
11.15.3 NYU Langone Transplant Institute Lung Transplant Introduction
11.15.4 NYU Langone Transplant Institute Revenue in Lung Transplant Business (2018-2023)
11.15.5 NYU Langone Transplant Institute Recent Development
11.16 University of Michigan Transplant Center
11.16.1 University of Michigan Transplant Center Company Detail
11.16.2 University of Michigan Transplant Center Business Overview
11.16.3 University of Michigan Transplant Center Lung Transplant Introduction
11.16.4 University of Michigan Transplant Center Revenue in Lung Transplant Business (2018-2023)
11.16.5 University of Michigan Transplant Center Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Mayo Clinic
UCSF
Penn medicine
Baylor College of Medicine
Cleveland Clinic
Stanford Health Care
University Health Network
Brigham and Women's Hospital
UC San Diego Health
Columbia Surgery
UMMC
Temple Lung Centre
UW Health
Duke Health
NYU Langone Transplant Institute
University of Michigan Transplant Center
听
听
*If Applicable.
